Influence of Diabetes on Antiplatelet Drug Efficacy

Clin Pharmacol Ther. 2018 Apr;103(4):572. doi: 10.1002/cpt.1005. Epub 2018 Jan 31.

Authors

Liying Gong^{1

2}, Yu Cao², Weijun Gu³, Jingle Li², Mingzhu Deng⁴, Guoping Yang¹

Affiliations

¹ The central of Clinical Pharmacology Center, Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
² Department of Cardiology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
³ Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.
⁴ Department of Neurology, Brain Hospital of Hunan Province, Changsha, Hunan, China.

PMID: 29383706
DOI: 10.1002/cpt.1005

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Clopidogrel
Electronic Health Records
Humans
Pharmacogenetics
Platelet Aggregation Inhibitors*
Stroke*

Substances

Platelet Aggregation Inhibitors
Clopidogrel